Outsourcing Motherhood: India's Reproductive Dystopia
By Namita Kohli,
Hindustan Times
| 07. 26. 2015
Untitled Document
It's early morning in the mid western state of Ohio in the US, but Michael Morris (name changed on request), 54, is excited to talk about his "India experience". About six months ago, Michael and his wife, in her early 50s, had a daughter through a surrogate mother in Delhi. "The medical aspect was first rate; we were able to see the surrogate mother, she was healthy; everything went well," Michael tells me over the phone, before pausing and adding, "I know many people would not have had an experience like ours. But there are reasons for that."
For one, Michael says he had travelled through Asia before, and so, unlike "other Westerners", wasn't "intimidated" by the country and "the way things work here". More importantly, Michael says the couple had a "great facilitator" who arranged everything from the drive from the airport to a good IVF clinic in India. "Having a baby in international surrogacy is much like dealing in the stock market; if I know I have a million dollars to invest, I need to go...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...